Antimicrobial Potential of Pomegranate and Lemon Extracts Alone or in Combination with Antibiotics against Pathogens
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25136943 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Grace Farhat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Education, Manchester Metropolitan University, Manchester M15 6BG, UK. Hauptthemen laut MEDLINE: Plant Extracts, Anti-Bacterial Agents, Pomegranate, Citrus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manchester Metropolitan University, Euromed company.
Abstract (Originalsprache)
Amidst the growing concern of antimicrobial resistance as a significant health challenge, research has emerged, focusing on elucidating the antimicrobial potential of polyphenol-rich extracts to reduce reliance on antibiotics. Previous studies explored the antifungal effects of extracts as potential alternatives to conventional therapeutic strategies. We aimed to assess the antibacterial and antifungal effects of standardised pomegranate extract (PE) and lemon extract (LE) using a range of Gram-negative and Gram-positive bacteria and two yeast species. Additionally, we assessed the antimicrobial activities of common antibiotics (Ciprofloxacin, Imipenem, Gentamicin, and Ceftazidime), either alone or in combination with extracts, against Staphylococcus aureus and Escherichia coli. PE displayed substantial antibacterial (primarily bactericidal) and antifungal effects against most pathogens, while LE exhibited antibacterial (mostly bacteriostatic) and antifungal properties to a lesser extent. When compared with antibiotics, PE showed a greater zone of inhibition (ZOI) than Ciprofloxacin and Ceftazidime (p < 0.01) and comparable ZOI to Gentamicin (p = 0.4) against Staphylococcus aureus. However, combinations of either PE or LE with antibiotics exhibited either neutral or antagonistic effects on antibiotic activity against Staphylococcus aureus and Escherichia coli. These findings contribute to the existing evidence regarding the antimicrobial effects of PE and LE. They add to the body of research suggesting that polyphenols exert both antagonistic and synergistic effects in antimicrobial activity. This highlights the importance of identifying optimal polyphenol concentrations that can enhance antibiotic activity and reduce antibiotic resistance. Further in vivo studies, starting with animal trials and progressing to human trials, may potentially lead to recommendation of these extracts for therapeutic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health and Education, Manchester Metropolitan University, Manchester M15 6BG, UK.
- Centre for Cardiovascular Science, Faculty of Medicine and Veterinary Medicine, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
- Faculty of Science and Engineering, Manchester Metropolitan University, Manchester M15 6BH, UK.
ORCID-Profile: Grace Farhat, Emad A S Al-Dujaili
Förderung
- Manchester Metropolitan University
- Euromed company
Zitieren
APA
Farhat, G., Cheng, L., Al-Dujaili, E. A. S., & Zubko, M. (2024). Antimicrobial Potential of Pomegranate and Lemon Extracts Alone or in Combination with Antibiotics against Pathogens. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136943
Vancouver
Farhat G, Cheng L, Al-Dujaili EAS, Zubko M. Antimicrobial Potential of Pomegranate and Lemon Extracts Alone or in Combination with Antibiotics against Pathogens. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136943
BibTeX
@article{Farhat2024,
author = {Farhat, Grace and Cheng, Lewis and Al-Dujaili, Emad A S and Zubko, Mikhajlo},
title = {Antimicrobial Potential of Pomegranate and Lemon Extracts Alone or in Combination with Antibiotics against Pathogens},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25136943}
}
EUVIMED